ERCP in Idiopathic Recurrent Acute Pancreatitis
Primary Purpose
Recurrent Acute Pancreatitis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Biliary sphincterotomy
Pancreatobiliary sphincterotomy
Sham
Sponsored by
About this trial
This is an interventional treatment trial for Recurrent Acute Pancreatitis focused on measuring Acute pancreatitis, ERCP, Sphincterotomy, Manometry, Sphincter of Oddi dysfunction
Eligibility Criteria
Inclusion Criteria:
- Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring hospitalization
- ERCP with SOM planned
Exclusion Criteria:
- Chronic pancreatitis
- Pancreas divisum
- Alternate etiology identified (e.g., CBD stone, IPMN)
- Inability to perform pancreatic manometry
- Pregnancy, age < 18, incarceration
- Inability to provide informed consent
Sites / Locations
- Indiana University Health University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Active Comparator
Sham Comparator
Active Comparator
Arm Label
Biliary sphincterotomy
Dual sphincterotomy
Sham
Biliary sphincterotomy - Normal SOM
Arm Description
Cutting of the biliary sphincter muscle alone
Cutting of both the biliary and pancreatic sphincter muscles.
Among patients with normal sphincter of Oddi manometry, patients will undergo no sphincterotomy (sham therapy).
Among patients with normal SOM, patients may be randomized to empiric biliary sphincterotomy alone.
Outcomes
Primary Outcome Measures
Recurrent acute pancreatitis
Patients will be followed post-ERCP for up to 10 years. The primary outcome is development of acute pancreatitis following the index ERCP, based on standard definitions.
Acute pancreatitis is defined as new onset of pancreatic-type abdominal pain with associated elevation in serum amylase or lipase > 3 times the upper limit of normal, OR radiographic findings consistent with acute pancreatitis.
Secondary Outcome Measures
Interval development of chronic pancreatitis
Determine the incidence of chronic pancreatitis during prolonged follow-up. Chronic pancreatitis is defined as characteristic changes on cross sectional imaging (CT or MRI/MRCP) or ERP (Cambridge classification).
Secondary assessment of risk factors for developing recurrent acute pancreatitis during follow-up
A post hoc analysis will be conducted to evaluate for independent factors associated with having recurrent acute pancreatitis during follow-up
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01583517
Brief Title
ERCP in Idiopathic Recurrent Acute Pancreatitis
Official Title
Defining the Role of ERCP in the Evaluation and Treatment of Idiopathic Recurrent Acute Pancreatitis
Study Type
Interventional
2. Study Status
Record Verification Date
October 2014
Overall Recruitment Status
Completed
Study Start Date
September 1997 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
October 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Indiana University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).
Detailed Description
Patients with idiopathic RAP, defined as ≥2 unexplained (per the treating physician) episodes of acute pancreatitis (based on standard criteria) requiring hospitalization, will be prospectively enrolled. All patients will undergo ERCP with manometry, with stratified randomization based on the assessment of pancreatic basal sphincter pressure. If <40mmHg, the patient will be randomized to sham or biliary sphincterotomy (BES). If ≥40mmHg, the patient will be randomized to BES or pancreatobiliary ("dual") sphincterotomy (DES).
Patients and physicians will not be blinded to the assignment group. Patients will be followed for up to 10 years to determine 1) incidence of RAP requiring hospitalization (using standard definitions) or 2) interval development of chronic pancreatitis (CP).
Differences between patients who did and did not develop RAP during follow-up will be compared to evaluate for factors associated with AP during follow-up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Recurrent Acute Pancreatitis
Keywords
Acute pancreatitis, ERCP, Sphincterotomy, Manometry, Sphincter of Oddi dysfunction
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
89 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Biliary sphincterotomy
Arm Type
Active Comparator
Arm Description
Cutting of the biliary sphincter muscle alone
Arm Title
Dual sphincterotomy
Arm Type
Active Comparator
Arm Description
Cutting of both the biliary and pancreatic sphincter muscles.
Arm Title
Sham
Arm Type
Sham Comparator
Arm Description
Among patients with normal sphincter of Oddi manometry, patients will undergo no sphincterotomy (sham therapy).
Arm Title
Biliary sphincterotomy - Normal SOM
Arm Type
Active Comparator
Arm Description
Among patients with normal SOM, patients may be randomized to empiric biliary sphincterotomy alone.
Intervention Type
Procedure
Intervention Name(s)
Biliary sphincterotomy
Intervention Description
Cutting of the biliary sphincter muscle.
Intervention Type
Procedure
Intervention Name(s)
Pancreatobiliary sphincterotomy
Intervention Description
Cutting of both the biliary and pancreatic sphincter muscles.
Intervention Type
Procedure
Intervention Name(s)
Sham
Intervention Description
No sphincterotomy is performed in patients randomized to sham with normal SOM.
Primary Outcome Measure Information:
Title
Recurrent acute pancreatitis
Description
Patients will be followed post-ERCP for up to 10 years. The primary outcome is development of acute pancreatitis following the index ERCP, based on standard definitions.
Acute pancreatitis is defined as new onset of pancreatic-type abdominal pain with associated elevation in serum amylase or lipase > 3 times the upper limit of normal, OR radiographic findings consistent with acute pancreatitis.
Time Frame
120 months
Secondary Outcome Measure Information:
Title
Interval development of chronic pancreatitis
Description
Determine the incidence of chronic pancreatitis during prolonged follow-up. Chronic pancreatitis is defined as characteristic changes on cross sectional imaging (CT or MRI/MRCP) or ERP (Cambridge classification).
Time Frame
120 months
Title
Secondary assessment of risk factors for developing recurrent acute pancreatitis during follow-up
Description
A post hoc analysis will be conducted to evaluate for independent factors associated with having recurrent acute pancreatitis during follow-up
Time Frame
120 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring hospitalization
ERCP with SOM planned
Exclusion Criteria:
Chronic pancreatitis
Pancreas divisum
Alternate etiology identified (e.g., CBD stone, IPMN)
Inability to perform pancreatic manometry
Pregnancy, age < 18, incarceration
Inability to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stuart Sherman, MD
Organizational Affiliation
Indiana University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Indiana University Health University Hospital
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
22982183
Citation
Cote GA, Imperiale TF, Schmidt SE, Fogel E, Lehman G, McHenry L, Watkins J, Sherman S. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis. Gastroenterology. 2012 Dec;143(6):1502-1509.e1. doi: 10.1053/j.gastro.2012.09.006. Epub 2012 Sep 11.
Results Reference
result
Learn more about this trial
ERCP in Idiopathic Recurrent Acute Pancreatitis
We'll reach out to this number within 24 hrs